BeOne Medicines (ONC) Assets Average (2016 - 2026)

BeOne Medicines (ONC) has reported Assets Average for 11 consecutive years, with $8.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 46.04% year-over-year to $8.9 billion in Q2 2026; TTM through Jun 2026 was $8.9 billion, a 46.04% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 20.32% from the prior year.
• Assets Average was $8.9 billion for Q2 2026 at BeOne Medicines, up from $8.4 billion in the prior quarter.
• Over five years, Assets Average peaked at $8.9 billion in Q2 2026 and troughed at $5.6 billion in Q3 2023.
• A 5-year average of $6.7 billion and a median of $6.1 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slipped 25.49% in 2023 and surged 46.04% in 2026, its largest moves.
• Over 5 years, Assets Average stood at $6.6 billion in 2022, then fell by 13.55% to $5.7 billion in 2023, then increased by 3.72% to $5.9 billion in 2024, then surged by 34.63% to $7.9 billion in 2025, then rose by 12.06% to $8.9 billion in 2026.
• The last three Assets Average figures came in at $8.9 billion (Q2 2026), $8.4 billion (Q1 2026), and $7.9 billion (Q4 2025), per Business Quant data.